Marval Biosciences marvalbiosciences.com


Marval Biosciences is an early stage company, developing contrast agents for use in X-ray and Computed Tomography (CT) Imaging. Marval's lead candidate, NCTX, targets cardiovascular imaging.

Marval Biosciences is an early stage company, developing contrast agents for use in X-ray and Computed Tomography (CT) Imaging. Marval's lead candidate, NCTX, targets cardiovascular imaging.

Company (Alive / Active)

Phone:

Fax:

1441 9th Avenue
Unite 2001
San Diego, 92101
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Marval Biosciences $7.9M Jul 26, 2012
Cerenis Therapeutics $246.3M Mar 26, 2015
Kereos $36.5M Jan 12, 2012
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Marval Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and methods for enhancing contrast in imaging Nov 10, 2006 Aug 31, 2010 Patent
Compositions and methods for enhancing contrast in imaging Apr 21, 2004 May 11, 2010 Patent